Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 71
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Neurosci ; 54(10): 7688-7709, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34668254

RESUMO

Progressive Supranuclear Palsy (PSP) is the most common atypical parkinsonism and exhibits hallmark symptomology including motor function impairment and dysexecutive dementia. In contrast to Parkinson's disease, the underlying pathology displays aggregation of the protein tau, which is also seen in disorders such as Alzheimer's disease. Currently, there are no pharmacological treatments for PSP, and drug discovery efforts are hindered by the lack of an animal model specific to PSP. Based on previous results and clinical pathology, it was hypothesized that viral deposition of tau in cholinergic neurons within the hindbrain would produce a tauopathy along neural connections to produce PSP-like symptomology and pathology. By using a combination of ChAT-CRE rats and CRE-dependent AAV vectors, wildtype human tau (the PSP-relevant 1N4R isoform; hTau) was expressed in hindbrain cholinergic neurons. Compared to control subjects (GFP), rats with tau expression displayed deficits in a variety of behavioural paradigms: acoustic startle reflex, marble burying, horizontal ladder and hindlimb motor reflex. Postmortem, the hTau rats had significantly reduced number of cholinergic pedunculopontine tegmentum and dopaminergic substantia nigra neurons, as well as abnormal tau deposits. This preclinical model has multiple points of convergence with the clinical features of PSP, some of which distinguish between PSP and Parkinson's disease.


Assuntos
Doenças do Sistema Nervoso , Paralisia Supranuclear Progressiva , Animais , Colinérgicos , Neurônios Colinérgicos/metabolismo , Humanos , Ratos , Paralisia Supranuclear Progressiva/genética , Tegmento Mesencefálico/metabolismo , Proteínas tau/genética , Proteínas tau/metabolismo
2.
Eur J Neurosci ; 53(8): 2835-2847, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33426708

RESUMO

Pedunculopontine nucleus (PPN) cholinergic neurons are implicated in freezing of gait in Parkinson's disease (PD) and motor stereotypy in normal animals, but the causal role of these neurons on specific gait parameters and treatment-induced dyskinesia remains speculative. Therefore, we examined whether selective cholinergic lesion of the rostral PPN affects PD motor and gait deficits, L-DOPA-induced dyskinesia and motor improvement, and DA-agonist-induced dyskinesia. Sprague-Dawley rats were assigned to one unilaterally lesioned group: Sham lesion, PPN cholinergic lesion with diphtheria urotensin II fusion toxin, medial forebrain bundle dopamine lesion with 6-hydroxydopamine, or dual acetylcholine and dopamine lesion. We used gait analysis and forepaw adjusting steps to examine PD gait and motor deficits. Forepaw adjusting steps were also used to assess motor improvement with L-DOPA treatment. The abnormal involuntary movements scale measured L-DOPA and dopamine D1- and D2-receptor agonist-induced dyskinesia. Lesions, verified via tyrosine hydroxylase and choline acetyltransferase immunohistochemistry reduced an average of 95% of nigral dopamine neurons and 80% of PPN cholinergic neurons, respectively. Rats receiving acetylcholine and dual lesion demonstrated enhanced freezing, and acetylcholine lesioned rats exhibited increased print area and stand index. Dopamine and dual lesion produced similar forepaw adjusting steps task on and off L-DOPA. Relative to DA lesioned rats, dual lesioned rats displayed reduced L-DOPA and DA agonist-induced dyskinesia at specific time points. Our results indicate that PPN cholinergic neurons affect gait parameters related to postural stability. Therefore, therapeutically targeting PPN cholinergic neurons could reduce intractable postural instability in PD without affecting motor benefits or side effects of L-DOPA treatment.


Assuntos
Discinesias , Transtornos Neurológicos da Marcha , Doença de Parkinson , Animais , Colinérgicos , Modelos Animais de Doenças , Marcha , Levodopa , Oxidopamina/toxicidade , Ratos , Ratos Sprague-Dawley
3.
J Am Chem Soc ; 142(44): 18907-18923, 2020 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-33095990

RESUMO

Pressure-induced polymerization of aromatic compounds leads to novel materials containing sp3 carbon-bonded networks. The choice of the molecular species and the control of their arrangement in the crystal structures via intermolecular interactions, such as the arene-perfluoroarene interaction, can enable the design of target polymers. We have investigated the crystal structure compression and pressure-induced polymerization reaction kinetics of two polycyclic 1:1 arene-perfluoroarene cocrystals, naphthalene/octafluoronaphthalene (NOFN) and anthracene/octafluoronaphthalene (AOFN), up to 25 and 30 GPa, respectively, using single-crystal synchrotron X-ray diffraction, infrared spectroscopy, and theoretical computations based on density-functional theory. Our study shows the remarkable pressure stability of the parallel arene-perfluoroarene π-stacking arrangement and a reduction of the interplanar π-stacking separations by ca. 19-22% before the critical reaction distance is reached. A further strong, discontinuous, and irreversible reduction along the stacking direction at 20 GPa in NOFN (18.8%) and 25 GPa in AOFN (8.7%) indicates the pressure-induced breakdown of π-stacking by formation of σ-bonded polymers. The association of the structural distortion with the occurrence of a chemical reaction is confirmed by a high-pressure kinetic study using infrared spectroscopy, indicating one-dimensional polymer growth. Structural predictions for the fully polymerized high-pressure phases consisting of highly ordered rods of hydrofluorocarbons are presented based on theoretical computations, which are in excellent agreement with the experimentally determined unit-cell parameters. We show that the polymerization takes place along the arene-perfluoroarene π-stacking direction and that the lateral extension of the columns depends on the extension of the arene and perfluoroarene molecules.

4.
Phys Chem Chem Phys ; 22(24): 13474-13478, 2020 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-32524105

RESUMO

We compare various calculation methods to determine the electronic structures and energy differences of the phases of VO2. We show that density functional methods in the form of GGA+U are able to describe the enthalpy difference (latent heat) between the rutile and M1 phases of VO2, and the effect of doping on the transition temperature and on the band gap of the M1 phase. An enthalpy difference of ΔE0 = -44.2 meV per formula unit, similar to the experimental value, is obtained if the randomly oriented spins of the paramagnetic rutile phase are treated by a non-collinear spin density functional calculation. The predicted change in the transition temperature of VO2 for Ge, Si or Mg doping is calculated and is in good agreement with the experiment data.

5.
Opt Express ; 27(3): 3618-3628, 2019 Feb 04.
Artigo em Inglês | MEDLINE | ID: mdl-30732379

RESUMO

We investigate the dielectric properties of the 4H and 6H polytypes of silicon carbide in the 0.1-19 THz range, below the fundamental transverse-optical phonons. Folding of the Brillouin zone due to the specific superlattice structure of the two polytypes leads to activation of acoustic phonon modes. We use a combination of ultrabroadband terahertz time-domain spectroscopy and simulations based on density-functional perturbation theory to observe and characterize these modes, including band splitting due to the dissimilar carbon and silicon sublattices of the structures, and an indirect measurement of the anisotropic sound velocities in the two polytypes.

6.
Eur J Neurosci ; 48(12): 3477-3497, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30339310

RESUMO

Progressive supranuclear palsy (PSP) is the most common atypical Parkinsonism. Although PSP shares some symptomology with Parkinson's disease (PD), PSP has a different underlying pathology characterized by tau aggregation. Furthermore, PSP sufferers respond poorly to PD medications and there are no effective alternative therapeutics. The development of both palliative and disease altering therapeutics has been hampered by the lack of an animal model that displays relevant PSP-like pathology and behavioral deficits. Previously, our lab found that in rats the selective removal of cholinergic pedunculopontine neurons (whose axonal projections overlap with areas of PSP pathology), mimics the extensive loss of cholinergic pedunculopontine neurons seen in PSP, and produces a unique PSP-like combination of deficits in: startle reflex, attention, and motor function. The present study extends those findings by allowing the lesion to incubate for over a year and compares behavioral and post-mortem pathology of pedunculopontine-cholinergic-lesioned and sham-lesioned rats. There was an early startle reflex deficit which did not improve over time. Progressive declines in motor function developed over the course of the year, including an increase in the number of "slips" while navigating various beams and poorly coordinated transitions from an elevated platform into homecages. Histological analysis discovered that the loss off cholinergic pedunculopontine neurons precipitated a significant loss of substantia nigra tyrosine hydroxylase-positive neurons and a significant enlargement of the lateral ventricles. The latter is a distinguishing feature between PSP and PD. This preclinical animal model of PSP has the potential to further our understanding of PSP and aid in the testing of potential therapeutic agents.


Assuntos
Colinérgicos/farmacologia , Neurônios Colinérgicos/patologia , Atividade Motora/efeitos dos fármacos , Paralisia Supranuclear Progressiva/tratamento farmacológico , Tegmento Mesencefálico/patologia , Acetilcolina/farmacologia , Animais , Neurônios Colinérgicos/efeitos dos fármacos , Modelos Animais de Doenças , Masculino , Doenças do Sistema Nervoso/tratamento farmacológico , Doenças do Sistema Nervoso/patologia , Ratos Long-Evans , Substância Negra/efeitos dos fármacos , Substância Negra/patologia , Paralisia Supranuclear Progressiva/fisiopatologia , Tegmento Mesencefálico/efeitos dos fármacos , Tirosina 3-Mono-Oxigenase/efeitos dos fármacos
7.
Am J Physiol Regul Integr Comp Physiol ; 311(1): R14-23, 2016 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-27122368

RESUMO

Estradiol (E2) decreases both water and saline intakes by female rats. The ERα and ERß subtypes are expressed in areas of the brain that control fluid intake; however, the role that these receptors play in E2's antidipsogenic and antinatriorexigenic effects have not been examined. Accordingly, we tested the hypothesis that activation of ERα and ERß decreases water and saline intakes by female rats. We found a divergence in E2's inhibitory effect on intake: activation of ERα decreased water intake, whereas activation of ERß decreased saline intake. E2 decreases expression of the angiotensin II type 1 receptor (AT1R), a receptor with known relevance to water and salt intakes, in multiple areas of the brain where ERα and ERß are differentially expressed. Therefore, we tested for agonist-induced changes in AT1R mRNA expression by RT-PCR and protein expression by analyzing receptor binding to test the hypothesis that the divergent effects of these ER subtypes are mediated by region-specific changes in AT1R expression. Although we found no changes in AT1R mRNA or binding in areas of the brain known to control fluid intake associated with agonist treatment, the experimental results replicate and extend previous findings that body weight changes mediate alterations in AT1R expression in distinct brain regions. Together, the results reveal selective effects of ER subtypes on ingestive behaviors, advancing our understanding of E2's inhibitory role in the controls of fluid intake by female rats.


Assuntos
Peso Corporal/fisiologia , Ingestão de Líquidos/fisiologia , Receptor alfa de Estrogênio/fisiologia , Receptor beta de Estrogênio/fisiologia , Receptor Tipo 1 de Angiotensina/biossíntese , Receptor Tipo 1 de Angiotensina/genética , Angiotensina II/farmacologia , Animais , Peso Corporal/efeitos dos fármacos , Química Encefálica/genética , Ingestão de Líquidos/efeitos dos fármacos , Estradiol/farmacologia , Receptor alfa de Estrogênio/efeitos dos fármacos , Receptor beta de Estrogênio/efeitos dos fármacos , Estrogênios/farmacologia , Feminino , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Ratos , Ratos Long-Evans , Receptor Tipo 1 de Angiotensina/efeitos dos fármacos
8.
J Neurosci ; 34(27): 9124-33, 2014 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-24990932

RESUMO

Patients with Parkinson's disease (PD) display significant sleep disturbances and daytime sleepiness. Dopaminergic treatment dramatically improves PD motor symptoms, but its action on sleep remains controversial, suggesting a causal role of nondopaminergic lesions in these symptoms. Because the pedunculopontine nucleus (PPN) regulates sleep and arousal, and in view of the loss of its cholinergic neurons in PD, the PPN could be involved in these sleep disorders. The aims of this study were as follows: (1) to characterize sleep disorders in a monkey model of PD; (2) to investigate whether l-dopa treatment alleviates sleep disorders; and (3) to determine whether a cholinergic PPN lesion would add specific sleep alterations. To this end, long-term continuous electroencephalographic monitoring of vigilance states was performed in macaques, using an implanted miniaturized telemetry device. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment induced sleep disorders that comprised sleep episodes during daytime and sleep fragmentation and a reduction of sleep efficiency at nighttime. It also induced a reduction in time spent in rapid eye movement (REM) sleep and slow-wave sleep and an increase in muscle tone during REM and non-REM sleep episodes and in the number of awakenings and movements. l-Dopa treatment resulted in a partial but significant improvement of almost all sleep parameters. PPN lesion induced a transient decrease in REM sleep and in slow-wave sleep followed by a slight improvement of sleep quality. Our data demonstrate the efficacy of l-dopa treatment in improving sleep disorders in parkinsonian monkeys, and that adding a cholinergic PPN lesion improves sleep quality after transient sleep impairment.


Assuntos
Levodopa/uso terapêutico , Intoxicação por MPTP/fisiopatologia , Transtornos Parkinsonianos/fisiopatologia , Núcleo Tegmental Pedunculopontino/fisiopatologia , Transtornos Intrínsecos do Sono/etiologia , Animais , Benserazida/farmacologia , Benserazida/uso terapêutico , Neurônios Colinérgicos/efeitos dos fármacos , Toxina Diftérica/genética , Toxina Diftérica/toxicidade , Combinação de Medicamentos , Levodopa/farmacologia , Intoxicação por MPTP/complicações , Intoxicação por MPTP/tratamento farmacológico , Macaca fascicularis , Masculino , Tono Muscular/efeitos dos fármacos , Tono Muscular/fisiologia , Transtornos Parkinsonianos/complicações , Transtornos Parkinsonianos/tratamento farmacológico , Núcleo Tegmental Pedunculopontino/lesões , Polissonografia , Proteínas Recombinantes de Fusão/toxicidade , Privação do Sono/tratamento farmacológico , Privação do Sono/etiologia , Privação do Sono/fisiopatologia , Transtornos Intrínsecos do Sono/tratamento farmacológico , Transtornos Intrínsecos do Sono/fisiopatologia , Sono REM/efeitos dos fármacos , Sono REM/fisiologia , Urotensinas/genética , Vigília/fisiologia
9.
J Neurosci ; 33(29): 11986-93, 2013 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-23864685

RESUMO

Gait and balance disorders unresponsive to dopaminergic drugs in Parkinson's disease (PD) are secondary to lesions located outside the dopaminergic system. However, available animal models of PD fail to display l-3,4-dihydroxyphenylalanine (DOPA)-responsive parkinsonism and drug-resistant gait and balance disorders, and this lack of appropriate model could account for the deficit of efficient treatments. Because the pedunculopontine nucleus (PPN) plays an important role in locomotion control, we conducted the present study to investigate the consequences of combined dopaminergic and PPN lesions in a same animal. We used macaques that received first 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication to render them parkinsonian and then local stereotaxic lesion of the PPN. Adding bilateral PPN lesions in MPTP-lesioned macaques induced dopamine-resistant gait and balance disorders but unexpectedly improved hypokinesia. Additional MPTP injections resulted in the association of a severe DOPA-responsive parkinsonism together with DOPA-unresponsive gait disorders. Histological examination assessed a severe dopaminergic degeneration and a significant loss of PPN cholinergic neurons. We observed similar results in aged monkeys intoxicated with MPTP: they developed severe DOPA-responsive hypokinesia and tremor together with unresponsive gait and balance disorders and displayed dopaminergic lesion and a weak but significant cholinergic PPN lesion. Our results highlight the complex role of the cholinergic PPN neurons in the pathophysiology of PD because its lesion induces a dual effect with an improvement of hypokinesia contrasting with a worsening of DOPA-unresponsive gait and balance disorders. Thus, we obtained a primate model of PD that could be useful to test symptomatic treatments for these heavily disabling symptoms.


Assuntos
Neurônios Colinérgicos/patologia , Neurônios Dopaminérgicos/patologia , Coxeadura Animal/fisiopatologia , Transtornos Parkinsonianos/fisiopatologia , Núcleo Tegmental Pedunculopontino/efeitos dos fármacos , 1-Metil-4-Fenil-1,2,3,6-Tetra-Hidropiridina , Animais , Comportamento Animal/efeitos dos fármacos , Comportamento Animal/fisiologia , Contagem de Células , Neurônios Colinérgicos/efeitos dos fármacos , Neurônios Colinérgicos/fisiologia , Neurônios Dopaminérgicos/efeitos dos fármacos , Neurônios Dopaminérgicos/fisiologia , Feminino , Coxeadura Animal/induzido quimicamente , Coxeadura Animal/patologia , Macaca fascicularis , Masculino , Transtornos Parkinsonianos/patologia , Núcleo Tegmental Pedunculopontino/patologia , Núcleo Tegmental Pedunculopontino/fisiopatologia , Substância Negra/efeitos dos fármacos , Substância Negra/patologia , Substância Negra/fisiopatologia
10.
Eur J Neurosci ; 40(10): 3526-37, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25208852

RESUMO

Sensorimotor gating is the state-dependent transfer of sensory information into a motor system. When this occurs at an early stage of the processing stream it enables stimuli to be filtered out or partially ignored, thereby reducing the demands placed on advanced systems. Prepulse inhibition (PPI) of the acoustic startle reflex (ASR) is the standard measure of sensorimotor gating. A brainstem-midbrain circuitry is widely viewed as mediating both PPI and ASR. In this circuitry, the pedunculopontine tegmental nucleus (PPTg) integrates sensory input and cortico-basal ganglia output and, via presumed cholinergic signaling, inhibits ASR-generating neurons within the reticular formation. Non-selective damage to all neuronal types within PPTg reduces PPI. We assessed whether this effect originates in the loss of cholinergic signaling by examining ASR and PPI in rats bearing non-selective (excitotoxic) or selective cholinergic (Dtx-UII) lesions of PPTg. Excitotoxic lesions had no effect on ASR but reduced PPI at all prepulse levels tested. In contrast, selective depletion of cholinergic neurons reduced ASR to the extent that PPI was not measurable with standard (10-20 s) inter-trial intervals. Subsequent testing revealed appreciable ASRs could be generated when the inter-trial interval was increased (180 s). Under these conditions, PPI was assessed and no deficits were found after lesions of cholinergic PPTg neurons. These results show that cholinergic output from PPTg is essential for rapidly regenerating the ASR, but has no influence on PPI. Results are discussed in terms of sensorimotor integration circuitry and psychiatric disorders that feature disrupted ASR and PPI.


Assuntos
Neurônios Colinérgicos/fisiologia , Núcleo Tegmental Pedunculopontino/fisiopatologia , Inibição Pré-Pulso/fisiologia , Reflexo de Sobressalto/fisiologia , Estimulação Acústica , Animais , Toxina Diftérica/toxicidade , Agonistas de Aminoácidos Excitatórios/toxicidade , Ácido Ibotênico/toxicidade , Masculino , Ratos Sprague-Dawley , Urotensinas/toxicidade
11.
Eur J Neurosci ; 40(8): 3224-36, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24995993

RESUMO

Anatomically and functionally located between basal ganglia and brainstem circuitry, the pedunculopontine tegmental nucleus (PPTg) is in a pivotal position to contribute to motor behavior. Studies in primates have reported akinesia and postural instability following destruction of the PPTg. In humans, the PPTg partially degenerates in Parkinson's disease and stimulation of this region is under investigation as a possible therapeutic. Studies in rats report no crude motor impairment following PPTg lesion, although a detailed assessment of the role of the PPTg in rat motor function has not been reported. Our studies applied motor tests generally used in rodent models of Parkinson's disease to rats bearing either excitotoxic damage to all neuronal populations within PPTg, or selective destruction of the cholinergic subpopulation created with the toxin Dtx-UII. Neither lesion type altered baseline locomotion. On the rotarod, excitotoxic lesions produced a persistent impairment on the accelerating, but not fixed speed, conditions. In the vermicelli handling task (a quantitative measure of fine motor control and effective behavioral sequencing) excitotoxic lesions produced no single impairment, but globally increased the number of normal and abnormal behaviors. In contrast, depletion of cholinergic PPTg neurons produced impairment on the accelerating rotarod but no changes in vermicelli handling. Together, these results show that while PPTg lesions produce no impairment in the execution of individual motor actions, impairments emerge when the demands of the task increase. Results are discussed in terms of PPTg acting as part of a rapid action selection system, which integrates sensory information into motor output.


Assuntos
Neurônios Colinérgicos/fisiologia , Atividade Motora/fisiologia , Neurônios/fisiologia , Núcleo Tegmental Pedunculopontino/fisiologia , Animais , Ácido Ibotênico/toxicidade , Masculino , Núcleo Tegmental Pedunculopontino/patologia , Ratos , Ratos Sprague-Dawley , Teste de Desempenho do Rota-Rod
12.
Am J Physiol Regul Integr Comp Physiol ; 307(12): R1396-404, 2014 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-25354729

RESUMO

Previous studies show that the angiotensin type 1 receptor (AT1R) is susceptible to rapid desensitization, but that more chronic treatments that stimulate ANG II lead to sensitization of several responses. It is unclear, however, if the processes of desensitization and sensitization interact. To test for differences in AT1R expression associated with single or repeated injections of ANG II, we measured AT1R mRNA in nuclei that control fluid intake of rats given ANG II either in a single injection or divided into three injections spaced 20 min apart. Rats given a single injection of ANG II had more AT1R mRNA in the subfornical organ (SFO) and the periventricular tissue surrounding the anteroventral third ventricle (AV3V) than did controls. The effect was not observed, however, when the same cumulative dose of ANG II was divided into multiple injections. Behavioral tests found that single daily injections of ANG II sensitized the dipsogenic response to ANG II, but a daily regimen of four injections did not cause sensitization. Analysis of (125)I-Sar(1)-ANG II binding revealed a paradoxical decrease in binding in the caudal AV3V and dorsal median preoptic nucleus after 5 days of single daily injections of ANG II; however, this effect was absent in rats treated for 5 days with four daily ANG II injections. Taken together, these data suggest that a desensitizing treatment regimen prevents behavior- and receptor-level effects of repeated daily ANG II.


Assuntos
Angiotensina II/administração & dosagem , Comportamento Animal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Ingestão de Líquidos/efeitos dos fármacos , Receptor Tipo 1 de Angiotensina/efeitos dos fármacos , Animais , Autorradiografia , Sítios de Ligação , Encéfalo/metabolismo , Regulação para Baixo , Esquema de Medicação , Tolerância a Medicamentos , Injeções Intraventriculares , Masculino , RNA Mensageiro/metabolismo , Ratos Sprague-Dawley , Receptor Tipo 1 de Angiotensina/genética , Receptor Tipo 1 de Angiotensina/metabolismo , Fatores de Tempo
13.
J Chem Phys ; 140(5): 054702, 2014 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-24511963

RESUMO

The electronic structure of vanadium sesquioxide V2O3 in its different phases has been calculated using the screened exchange hybrid density functional. The hybrid functional accurately reproduces the experimental electronic properties of all three phases, the paramagnetic metal (PM) phase, the anti-ferromagnetic insulating phase, and the Cr-doped paramagnetic insulating (PI) phase. We find that a fully relaxed supercell model of the Cr-doped PI phase based on the corundum structure has a monoclinic-like local strain around the substitutional Cr atoms. This is found to drive the PI-PM transition, consistent with a Peierls-Mott transition. The PI phase has a calculated band gap of 0.15 eV, in good agreement with experiment.

14.
BMJ Open Qual ; 13(1)2024 02 26.
Artigo em Inglês | MEDLINE | ID: mdl-38413094

RESUMO

BACKGROUND: Avoidable patient harm in hospitals is common, and doctors in training can provide underused but crucial insights into the influencers of patient safety as those working 'on the ground' within the system. This study aimed to explore the factors that influence safe care from the perspective of medical registrars, to identify targets for safety-related improvements. METHODS: This study used enhanced critical incident technique (CIT), a qualitative methodology that results in a focused understanding of significant factors influencing an activity, to identify practical solutions. We interviewed 12 out of 17 consenting medical registrars in Scotland, asking them to recount their observations during clinical experiences where something happened that positively or negatively impacted on patient safety. Data were analysed manually using a modified content analysis with credibility checks as per enhanced CIT, with data exhaustiveness reached after six registrars. RESULTS: A total of 221 critical incidents impacting patient safety were identified. These were inductively placed into 24 categories within 4 overarching categories: Individual skills, encompassing individual behavioural and technical skills; Collaboration, regarding how communication, trust, support and flexibility shape interprofessional collaboration; Organisation, concerning organisational systems and staffing and Training environment, relating to culture, civility, having a voice and learning at work. Practical targets for safety-related interventions were identified, such as clear policies for patient care ownership or educational interventions to foster civility. CONCLUSIONS: This study provides a rigorous and focused understanding of the factors influencing patient safety in hospitals, using the 'insider' perspective of the medical registrar. Safety goes beyond the individual and is reliant on safe system design, interprofessional collaboration and a culture of support, learning and respect. Organisations should also promote flexibility within clinical practice when patient needs do not conform to standardised care pathways. We suggest targeted interventions within educational and organisational priorities to improve safety in hospitals.


Assuntos
Médicos , Análise e Desempenho de Tarefas , Humanos , Pessoal de Saúde , Segurança do Paciente , Aprendizagem
15.
Inorg Chem ; 52(4): 2078-85, 2013 Feb 18.
Artigo em Inglês | MEDLINE | ID: mdl-23350805

RESUMO

The quaternary transition metal oxyselenide La(2)O(2)ZnSe(2) has been shown to adopt a ZrCuSiAs-related structure with Zn(2+) cations in a new ordered arrangement within the [ZnSe(2)](2-) layers. This cation-ordered structure can be derived and described using the symmetry-adapted distortion mode approach. La(2)O(2)ZnSe(2) is an direct gap semiconductor with an experimental optical band gap of 3.4(2) eV, consistent with electronic structure calculations.

16.
Sci Rep ; 13(1): 16854, 2023 Oct 06.
Artigo em Inglês | MEDLINE | ID: mdl-37803050

RESUMO

The structural stability and internal properties of hybrid organic-inorganic perovskites (HOIPs) have been widely investigated over the past few years. The interplay between organic cations and inorganic framework is one of the prominent features. Herein we report the evolution of Raman modes under pressure in the hybrid organic-inorganic perovskite MAPbI[Formula: see text] by combining the experimental approach with the first-principles calculations. A bulk MAPbI[Formula: see text] single crystal was synthesized via inverse temperature crystallization (ITC) technique and characterized by Raman spectroscopy, while the diamond anvil cells (DACs) was employed to compress the sample. The classification and behaviours of their Raman modes are presented. At ambient pressure, the vibrations of inorganic PbI[Formula: see text] octahedra and organic MA dominate at a low-frequency range (60-760 cm[Formula: see text]) and a fingerprint range (900-1500 cm[Formula: see text]), respectively. The applied pressure exhibits two significant changes in the Raman spectrum and indicates of phase transition. The results obtained from both experiment and calculations of the second phase at 3.26 GPa reveal that the internal vibration intensity of the PbI[Formula: see text] octahedra (< 110 cm[Formula: see text]) reduces as absences of MA libration (150-270 cm[Formula: see text]) and internal vibration of MA (450-750 cm[Formula: see text]). Furthermore, the hydrogen interactions around 1300 cm[Formula: see text] remain strong high pressure up to 5.34 GPa.

17.
Neuropharmacology ; 241: 109743, 2023 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-37820934

RESUMO

Neuropeptide S (NPS) is a neuromodulatory peptide that acts via a G protein-coupled receptor. Centrally administered NPS suppresses anxiety-like behaviors in rodents while producing a paradoxical increase in arousal. In addition, NPS increases drug-seeking behavior when administered during cue-induced reinstatement. Conversely, an NPS receptor (NPSR) antagonist, RTI-118, decreases cocaine-seeking behavior. A biased NPSR ligand, RTI-263, produces anxiolytic-like effects and has memory-enhancing effects similar to those of NPS but without the increase in arousal. In the present study, we show that RTI-263 decreased cocaine seeking by both male and female rats during cue-induced reinstatement. However, RTI-263 did not modulate the animals' behaviors during natural reward paradigms, such as palatable food intake, feeding during a fasting state, and cue-induced reinstatement of sucrose seeking. Therefore, NPSR biased agonists are a potential pharmacotherapy for substance use disorder because of the combined benefits of decreased drug seeking and the suppression of anxiety.


Assuntos
Ansiolíticos , Cocaína , Neuropeptídeos , Feminino , Ratos , Masculino , Animais , Cocaína/farmacologia , Ansiolíticos/farmacologia , Ansiolíticos/uso terapêutico , Receptores Acoplados a Proteínas G , Comportamento Animal , Comportamento de Procura de Droga , Neuropeptídeos/farmacologia , Autoadministração , Sinais (Psicologia) , Extinção Psicológica
18.
Res Sq ; 2023 Jun 02.
Artigo em Inglês | MEDLINE | ID: mdl-37398410

RESUMO

Single allelic mutations in the gene encoding the forebrain-specific transcription factor FOXG1 lead to FOXG1 syndrome (FS). Patient-specific animal models are needed to understand the etiology of FS, as FS patients show a wide spectrum of symptoms correlated with location and mutation type in the FOXG1 gene. Here we report the first patient-specific FS mouse model, Q84Pfs heterozygous (Q84Pfs-Het) mice, mimicking one of the most predominant single nucleotide variants in FS. Intriguingly, we found that Q84Pfs-Het mice faithfully recapitulate human FS phenotypes at the cellular, brain structural, and behavioral levels. Importantly, Q84Pfs-Het mice exhibited myelination deficits like FS patients. Further, our transcriptome analysis of Q84Pfs-Het cortex revealed a new role for FOXG1 in synapse and oligodendrocyte development. The dysregulated genes in Q84Pfs-Het brains also predicted motor dysfunction and autism-like phenotypes. Correspondingly, Q84Pfs-Het mice showed movement deficits, repetitive behaviors, increased anxiety, and prolonged behavior arrest. Together, our study revealed the crucial postnatal role of FOXG1 in neuronal maturation and myelination and elucidated the essential pathophysiology mechanisms of FS.

19.
Curr Biol ; 33(24): 5439-5455.e7, 2023 12 18.
Artigo em Inglês | MEDLINE | ID: mdl-38056461

RESUMO

Neuropeptide S (NPS) is a highly conserved peptide found in all tetrapods that functions in the brain to promote heightened arousal; however, the subpopulations mediating these phenomena remain unknown. We generated mice expressing Cre recombinase from the Nps gene locus (NpsCre) and examined populations of NPS+ neurons in the lateral parabrachial area (LPBA), the peri-locus coeruleus (peri-LC) region of the pons, and the dorsomedial thalamus (DMT). We performed brain-wide mapping of input and output regions of NPS+ clusters and characterized expression patterns of the NPS receptor 1 (NPSR1). While the activity of all three NPS+ subpopulations tracked with vigilance state, only NPS+ neurons of the LPBA exhibited both increased activity prior to wakefulness and decreased activity during REM sleep, similar to the behavioral phenotype observed upon NPSR1 activation. Accordingly, we found that activation of the LPBA but not the peri-LC NPS+ neurons increased wake and reduced REM sleep. Furthermore, given the extended role of the LPBA in respiration and the link between behavioral arousal and breathing rate, we demonstrated that the LPBA but not the peri-LC NPS+ neuronal activation increased respiratory rate. Together, our data suggest that NPS+ neurons of the LPBA represent an unexplored subpopulation regulating breathing, and they are sufficient to recapitulate the sleep/wake phenotypes observed with broad NPS system activation.


Assuntos
Neuropeptídeos , Camundongos , Animais , Neuropeptídeos/genética , Neuropeptídeos/metabolismo , Nível de Alerta/fisiologia , Encéfalo/fisiologia , Vigília/fisiologia , Sono/fisiologia , Neurônios/fisiologia , Respiração
20.
Phys Rev Lett ; 109(26): 265502, 2012 Dec 28.
Artigo em Inglês | MEDLINE | ID: mdl-23368579

RESUMO

We present a systematic ab initio density functional theory-based study which demonstrates that even one of the simplest defects in single-wall carbon nanotubes, the reconstructed monovacancy (a pentagonal ring and a single dangling bond known as a 5-1db defect), leads to extraordinarily long-ranged structural distortions. We show that relaxation due to reconstruction can only be modeled accurately through a careful selection of boundary conditions and an appropriately long nanotube fragment.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA